title: Aspirin resistance: a clinical review focused on the most common cause, noncompliance.
abstract: Aspirin is an inexpensive, readily available medication that reduces the risk of subsequent vascular disease by about 25% in patients with known occlusive vascular disease. Aspirin's beneficial effect is mediated via inhibition of arachidonic acid (AA) activation of platelets and is detected by demonstrating a decrease in platelet function and/or a decrease in prostaglandin metabolites. Patients who are assumed to be taking their aspirin, but who do not demonstrate an aspirin effect are labeled as, "aspirin resistant." This is an unfortunate designation as the vast majority of patients labeled as "aspirin resistant" are noncompliant. Noncompliance is demonstrated in multiple studies that use repeat testing for platelet inhibition in patients with an initial inadequate response to aspirin. When the test is repeated under condition where ingestion of the test aspirin is assured, the patients' platelets are inhibited. Instead of using the term "aspirin resistance," this review will use "inadequate response to aspirin." Patients with an inadequate aspirin response have an increased likelihood for subsequent vascular events. Detection and treatment of an inadequate aspirin response would be facilitated by the development of a bedside assay that uses whole blood, is technically simple, inexpensive, sensitive, specific, reproducible, and provides an answer in a few minutes. Future research in patients with an inadequate response to aspirin should focus on mechanisms to improve compliance, which should decrease their risk of future vascular events.
authors: Department of Medicine, Division of Hematology/Oncology, Michigan State University, East Lansing, Michigan, USA.
authors: Kenneth A
authors: KA
authors: Schwartz
keywords: aspirin; intracranial arteriosclerosis; platelets
references: Arch Intern Med. 2004 Apr 26;164(8):852-6
references: 15111370
references: Am Heart J. 2007 Feb;153(2):175-81
references: 17239674
references: J Clin Invest. 1969 Jun;48(6):963-74
references: 5814231
references: Circulation. 2004 Jun 22;109(24):3000-6
references: 15197149
references: Arch Intern Med. 2006 Sep 25;166(17):1842-7
references: 17000940
references: Thromb Res. 2003 Jun 15;110(5-6):281-6
references: 14592549
references: J Transl Med. 2008 Aug 29;6:46
references: 18759978
references: Proc Natl Acad Sci U S A. 2002 May 28;99(11):7634-9
references: 12032335
references: Am Heart J. 2004 Feb;147(2):293-300
references: 14760328
references: N Engl J Med. 1984 Nov 8;311(19):1206-11
references: 6436696
references: Platelets. 2008 Mar;19(2):119-24
references: 18297549
references: BMJ. 2008 Jan 26;336(7637):195-8
references: 18202034
references: Thromb Res. 1993 Sep 1;71(5):397-403
references: 8236166
references: J Thromb Haemost. 2006 Feb;4(2):312-9
references: 16420557
references: Circulation. 2003 Aug 5;108(5):542-7
references: 12874188
references: Lancet. 2003 Feb 15;361(9357):573-4
references: 12598144
references: Circulation. 2003 Sep 9;108(10):1191-5
references: 12939216
references: Thromb Haemost. 2005 Oct;94(4):889-91
references: 16270651
references: Am J Cardiol. 2005 Apr 15;95(8):973-5
references: 15820166
references: Am Heart J. 2009 May;157(5):889-93
references: 19376317
references: Arteriosclerosis. 1983 Jul-Aug;3(4):383-8
references: 6411052
references: Stroke. 1994 Dec;25(12):2337-42
references: 7974570
references: J Lab Clin Med. 2002 Apr;139(4):227-33
references: 12024110
references: J Neurol. 2003 Jan;250(1):63-6
references: 12527994
references: Lancet. 2006 Feb 18;367(9510):606-17
references: 16488805
references: Thromb Haemost. 2008 Jan;99(1):14-26
references: 18217130
references: Semin Thromb Hemost. 2007 Mar;33(2):210-4
references: 17340471
references: Clin Neurol Neurosurg. 2009 Apr;111(3):270-3
references: 19084329
references: Thromb Haemost. 2008 Sep;100(3):379-90
references: 18766252
references: N Engl J Med. 2001 Dec 20;345(25):1809-17
references: 11752357
references: Adv Clin Chem. 2006;42:81-110
references: 17131625
references: Br J Haematol. 2004 Jan;124(1):80-5
references: 14675411
references: Eur Heart J. 2007 Jul;28(14):1702-8
references: 17569678
references: J Physiol Pharmacol. 1999 Dec;50(4):661-7
references: 10639016
references: Circulation. 2006 Jun 27;113(25):2888-96
references: 16785341
references: Blood. 1994 Feb 15;83(4):885-98
references: 8111062
references: Am J Med. 2007 Jul;120(7):631-5
references: 17602938
references: Thromb Res. 2008;123(2):267-73
references: 18499236
references: Arch Intern Med. 2007 Aug 13-27;167(15):1593-9
references: 17698681
references: N Engl J Med. 1972 Nov 16;287(20):999-1005
references: 4675535
references: J Am Coll Cardiol. 2005 Nov 1;46(9):1705-9
references: 16256872
references: Thromb Haemost. 2004 Jul;92(1):89-96
references: 15213849
references: Blood. 1987 Jan;69(1):180-6
references: 3790723
references: BMJ. 2002 Jan 12;324(7329):71-86
references: 11786451
references: Clin Chem. 2008 Jun;54(6):1060-5
references: 18420732
references: J Clin Invest. 1986 Feb;77(2):590-4
references: 3944270
references: J Am Coll Cardiol. 2003 Mar 19;41(6):961-5
references: 12651041
references: Blood Coagul Fibrinolysis. 2008 Apr;19(3):235-9
references: 18388505